|
G3BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4980999999924E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.212530E-04 |
| Normal-vs-Stage2 |
7.537400E-03 |
| Normal-vs-Stage3 |
1.776950E-04 |
| Normal-vs-Stage4 |
4.06149999998551E-06 |
| Stage1-vs-Stage2 |
9.286800E-01 |
| Stage1-vs-Stage3 |
6.038600E-01 |
| Stage1-vs-Stage4 |
1.075780E-01 |
| Stage2-vs-Stage3 |
6.866400E-01 |
| Stage2-vs-Stage4 |
2.777000E-01 |
| Stage3-vs-Stage4 |
3.364200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.581500E-04 |
| Normal-vs-AfricanAmerican |
2.132200E-02 |
| Normal-vs-Asian |
2.186600E-04 |
| Caucasian-vs-AfricanAmerican |
8.147400E-01 |
| Caucasian-vs-Asian |
4.286400E-01 |
| AfricanAmerican-vs-Asian |
4.470600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.70359999998693E-06 |
| Normal-vs-Female |
1.751940E-04 |
| Male-vs-Female |
8.084000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.517350E-03 |
| Normal-vs-Age(41-60Yrs) |
1.74975999999161E-05 |
| Normal-vs-Age(61-80Yrs) |
3.8972000000026E-05 |
| Normal-vs-Age(81-100Yrs) |
3.478200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.638030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.003200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.673600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.000800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.884800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.649200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.892000E-01 |
| Classical-VS-Follicular |
9.93900000079151E-08 |
| Classical-VS-Other |
1.027030E-01 |
| Classical-VS-Normal |
3.036000E-03 |
| Tall-VS-Follicular |
3.138300E-03 |
| Tall-VS-Other |
1.567970E-01 |
| Tall-VS-Normal |
3.467600E-02 |
| Follicular-VS-Other |
9.153600E-01 |
| Follicular-VS-Normal |
9.94009985433308E-10 |
| Other-VS-Normal |
7.076800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.19119999999018E-05 |
| Normal-vs-N1 |
4.56869999998499E-06 |
| N0-vs-N1 |
3.357400E-01 |
|
|
